MX9400254A - Composicion farmaceutica para el tratamiento de la aterosclerosis. - Google Patents
Composicion farmaceutica para el tratamiento de la aterosclerosis.Info
- Publication number
- MX9400254A MX9400254A MX9400254A MX9400254A MX9400254A MX 9400254 A MX9400254 A MX 9400254A MX 9400254 A MX9400254 A MX 9400254A MX 9400254 A MX9400254 A MX 9400254A MX 9400254 A MX9400254 A MX 9400254A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- atherosclerosis
- pharmaceutical composition
- ester
- dihydroequilin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Se presenta un método de tratamiento de la aterosclerosis administrando a un paciente que necesita el tratamiento antiaterosclerótico una cantidad efectiva de 17Ó-dihidroequilina o uno de sus fármacos como por ejemplo, uno de sus ésteres alcanoiloxi C2-C6 o una sal farmacéuticamente aceptable de su éster sulfúrico o fosfórico, en ausencia de esteroides estrogénicos naturales. Una composición farmacéutica que contiene 17Ó-dihidroequilina, uno de sus ésteres alcanoiloxi C2-C6 o una sal farmacéuticamente aceptable de su éster sulfúrico o fosfórico, en ausencia de esteroides estrogénicos naturales, y un vehículo farmacéuticamente aceptable para los citados productos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77793A | 1993-01-05 | 1993-01-05 | |
| US08/157,661 US5482935A (en) | 1993-01-05 | 1993-12-01 | Anti-atherosclerotic use of 17 alpha-dihydroequilin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9400254A true MX9400254A (es) | 1994-08-31 |
Family
ID=26668138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9400254A MX9400254A (es) | 1993-01-05 | 1994-01-04 | Composicion farmaceutica para el tratamiento de la aterosclerosis. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0678027B1 (es) |
| JP (1) | JP3344585B2 (es) |
| CN (1) | CN1071573C (es) |
| AT (1) | ATE209495T1 (es) |
| AU (1) | AU6015794A (es) |
| CA (1) | CA2152187A1 (es) |
| CY (1) | CY2361B1 (es) |
| DE (1) | DE69331237T2 (es) |
| DK (1) | DK0678027T3 (es) |
| ES (1) | ES2165382T3 (es) |
| HK (1) | HK1011282A1 (es) |
| IL (1) | IL108155A (es) |
| MX (1) | MX9400254A (es) |
| PH (1) | PH30474A (es) |
| PT (1) | PT678027E (es) |
| SG (1) | SG52359A1 (es) |
| WO (1) | WO1994015612A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6855703B1 (en) * | 2000-03-10 | 2005-02-15 | Endeavor Pharmaceuticals | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3507889A (en) * | 1968-06-11 | 1970-04-21 | American Home Prod | Process for the preparation of 17alpha-dihydroequilenin and related compounds |
| US3608075A (en) * | 1969-07-28 | 1971-09-21 | American Home Prod | Compositions and methods of treating the menopausal syndrome |
| US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
| US4379780A (en) * | 1980-09-29 | 1983-04-12 | American Home Products Corporation | 17 α-Dihydroequilin hapten and assay method |
-
1993
- 1993-12-22 DE DE69331237T patent/DE69331237T2/de not_active Expired - Fee Related
- 1993-12-22 PT PT94906461T patent/PT678027E/pt unknown
- 1993-12-22 CA CA002152187A patent/CA2152187A1/en not_active Abandoned
- 1993-12-22 AU AU60157/94A patent/AU6015794A/en not_active Abandoned
- 1993-12-22 ES ES94906461T patent/ES2165382T3/es not_active Expired - Lifetime
- 1993-12-22 SG SG1996003424A patent/SG52359A1/en unknown
- 1993-12-22 WO PCT/US1993/012559 patent/WO1994015612A1/en active IP Right Grant
- 1993-12-22 AT AT94906461T patent/ATE209495T1/de not_active IP Right Cessation
- 1993-12-22 EP EP94906461A patent/EP0678027B1/en not_active Expired - Lifetime
- 1993-12-22 DK DK94906461T patent/DK0678027T3/da active
- 1993-12-22 JP JP51605594A patent/JP3344585B2/ja not_active Expired - Fee Related
- 1993-12-23 IL IL10815593A patent/IL108155A/en not_active IP Right Cessation
- 1993-12-28 PH PH47563A patent/PH30474A/en unknown
-
1994
- 1994-01-04 MX MX9400254A patent/MX9400254A/es not_active IP Right Cessation
- 1994-01-04 CN CN94100239A patent/CN1071573C/zh not_active Expired - Fee Related
-
1998
- 1998-11-24 HK HK98112283A patent/HK1011282A1/xx not_active IP Right Cessation
-
2003
- 2003-05-15 CY CY0300043A patent/CY2361B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69331237D1 (de) | 2002-01-10 |
| HK1011282A1 (en) | 1999-07-09 |
| ES2165382T3 (es) | 2002-03-16 |
| CY2361B1 (en) | 2004-06-04 |
| IL108155A (en) | 1999-08-17 |
| EP0678027B1 (en) | 2001-11-28 |
| EP0678027A1 (en) | 1995-10-25 |
| ATE209495T1 (de) | 2001-12-15 |
| PH30474A (en) | 1997-05-28 |
| DK0678027T3 (da) | 2002-03-18 |
| CN1071573C (zh) | 2001-09-26 |
| WO1994015612A1 (en) | 1994-07-21 |
| AU6015794A (en) | 1994-08-15 |
| SG52359A1 (en) | 1998-09-28 |
| JP3344585B2 (ja) | 2002-11-11 |
| IL108155A0 (en) | 1994-04-12 |
| CN1096443A (zh) | 1994-12-21 |
| DE69331237T2 (de) | 2002-06-13 |
| PT678027E (pt) | 2002-04-29 |
| CA2152187A1 (en) | 1994-07-21 |
| JPH08505392A (ja) | 1996-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
| ES2074124T5 (es) | Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal. | |
| BR9604880A (pt) | Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica | |
| BG104476A (en) | Therapeutical form for tolterodin with controlled release | |
| DE122007000006I1 (de) | Hautpflaster enthaltend Testosteron und gegebenenfalls Estrogen | |
| BR9510168A (pt) | Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição | |
| HK1031197A1 (en) | Osmotic dosage form comprising first and second coats | |
| CA2213339A1 (en) | Method of treating adenosine depletion | |
| PL329802A1 (en) | Derivatives of androstene | |
| TW325996B (en) | Anti-atherosclerotic composition containing 17α-dihydroequilin | |
| AU3139097A (en) | Methods of preventing skeletal problems in poultry | |
| WO2001030802A3 (en) | Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies | |
| CA2157142A1 (en) | Treatment of diseases caused by sebaceous gland disorders | |
| ES2147788T3 (es) | 3,4-diarilcromanos para el tratamiento de la dermatitis. | |
| BG104436A (en) | The administration of macrolides for the treatment of cancer and macular degeneration | |
| EP1294375A4 (en) | METHOD FOR THE TREATMENT OF SEBORRHOIC DERMATITIS | |
| MX9400254A (es) | Composicion farmaceutica para el tratamiento de la aterosclerosis. | |
| FI956028A0 (fi) | Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät | |
| UA41881C2 (uk) | Лікарській засіб для лікування або профілактики запалення та спосіб лікування або профілактики запалення (варіанти) | |
| CO5031290A1 (es) | Formulacion lo | |
| ES2161809T3 (es) | Uso de factor proliferativo osteoblastico. | |
| UA42749C2 (uk) | N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування | |
| PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances | |
| UA30359A (uk) | Спосіб лікування гнійних ран | |
| MY104932A (en) | Immunomodulatory azaspiranes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| HC | Change of company name or juridical status |
Owner name: BASF AGRO B.V., ARNHEM (NL), WAEDENSWIL-BRANCH |
|
| MM | Annulment or lapse due to non-payment of fees |